Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 3
1983 4
1984 2
1985 3
1986 2
1987 4
1988 1
1989 6
1990 5
1991 4
1992 10
1993 8
1994 14
1995 8
1996 5
1997 7
1998 11
1999 8
2000 6
2001 10
2002 10
2003 6
2004 7
2005 3
2006 9
2007 4
2008 12
2009 19
2010 7
2011 5
2012 9
2013 3
2014 7
2015 10
2016 9
2017 6
2018 5
2019 7
2020 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

254 results

Results by year

Filters applied: . Clear all
Page 1
Is the liver a tolerogenic organ?
Calmus Y, Conti F. Calmus Y, et al. Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):655-8. doi: 10.1016/j.clinre.2014.08.009. Epub 2014 Sep 26. Clin Res Hepatol Gastroenterol. 2014. PMID: 25260569 No abstract available.
The Authors' Reply.
Mazzola A, Tran Minh M, Charlotte F, Hdiji A, Bernard D, Wendum D, Calmus Y, Conti F. Mazzola A, et al. Among authors: calmus y. Transplantation. 2018 Feb;102(2):e85-e86. doi: 10.1097/TP.0000000000001995. Transplantation. 2018. PMID: 29135856 No abstract available.
Liver transplantation using grafts with rare metabolic disorders.
Schielke A, Conti F, Goumard C, Perdigao F, Calmus Y, Scatton O. Schielke A, et al. Among authors: calmus y. Dig Liver Dis. 2015 Apr;47(4):261-70. doi: 10.1016/j.dld.2014.11.004. Epub 2014 Nov 13. Dig Liver Dis. 2015. PMID: 25498135 Free article. Review.
Immunosuppressive therapy in liver transplantation.
Conti F, Morelon E, Calmus Y. Conti F, et al. Among authors: calmus y. J Hepatol. 2003 Nov;39(5):664-78. doi: 10.1016/s0168-8278(03)00428-8. J Hepatol. 2003. PMID: 14568246 Review. No abstract available.
NAFLD and liver transplantation: Current burden and expected challenges.
Pais R, Barritt AS 4th, Calmus Y, Scatton O, Runge T, Lebray P, Poynard T, Ratziu V, Conti F. Pais R, et al. Among authors: calmus y. J Hepatol. 2016 Dec;65(6):1245-1257. doi: 10.1016/j.jhep.2016.07.033. Epub 2016 Jul 30. J Hepatol. 2016. PMID: 27486010 Free PMC article. Review.
Use of everolimus in liver transplantation: The French experience.
Dumortier J, Dharancy S, Calmus Y, Duvoux C, Durand F, Salamé E, Saliba F. Dumortier J, et al. Among authors: calmus y. Transplant Rev (Orlando). 2016 Jul;30(3):161-70. doi: 10.1016/j.trre.2015.12.003. Epub 2016 Mar 18. Transplant Rev (Orlando). 2016. PMID: 27083870 Review.
Why actively promote vaccination in patients with cirrhosis?
Loulergue P, Pol S, Mallet V, Sogni P, Launay O; GEVACCIM Group. Loulergue P, et al. J Clin Virol. 2009 Nov;46(3):206-9. doi: 10.1016/j.jcv.2009.05.006. Epub 2009 Jun 4. J Clin Virol. 2009. PMID: 19501019 Review.
Review article: use of induction therapy in liver transplantation.
Rostaing L, Saliba F, Calmus Y, Dharancy S, Boillot O. Rostaing L, et al. Among authors: calmus y. Transplant Rev (Orlando). 2012 Oct;26(4):246-60. doi: 10.1016/j.trre.2012.06.002. Epub 2012 Aug 3. Transplant Rev (Orlando). 2012. PMID: 22863028 Review.
254 results